AKT1 and cancer: Moreover, the concurrent overactivation of CD147 and CD44 strongly sparks AKT pro-survival signaling, protecting circulating cancer cells from anoikis [41] and strengthening their resistance to chemotherapy and/or radiotherapy [33,222,223,224].